Jiro Minami

804 total citations
21 papers, 266 citations indexed

About

Jiro Minami is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jiro Minami has authored 21 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jiro Minami's work include Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Jiro Minami is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Jiro Minami collaborates with scholars based in Japan, United States and United Kingdom. Jiro Minami's co-authors include Naoya Mimura, Kenneth C. Anderson, Teru Hideshima, Paul G. Richardson, Diana Cirstea, Hiroto Ohguchi, Güllü Görgün, Yu‐Tzu Tai, Jana Jakubı́ková and Yasuhiro Yoshida and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Jiro Minami

20 papers receiving 265 citations

Peers

Jiro Minami
Marcos J. Ruiz United States
Alessandra Pirola Italy
Jennifer Richmond Australia
Gary Simmons United States
Juliana M. Benito United States
Stephanie Nguyen Australia
Ling Sun China
Tracey Perry United Kingdom
Amanda L. Robichaud United States
Vladimir Vorobyev Russia
Marcos J. Ruiz United States
Jiro Minami
Citations per year, relative to Jiro Minami Jiro Minami (= 1×) peers Marcos J. Ruiz

Countries citing papers authored by Jiro Minami

Since Specialization
Citations

This map shows the geographic impact of Jiro Minami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Minami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Minami more than expected).

Fields of papers citing papers by Jiro Minami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Minami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Minami. The network helps show where Jiro Minami may publish in the future.

Co-authorship network of co-authors of Jiro Minami

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Minami. A scholar is included among the top collaborators of Jiro Minami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Minami. Jiro Minami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Kazuhito, Nobuyuki Kobayashi, Yoji Ogasawara, et al.. (2018). Clinical significance of cancer-related fatigue in multiple myeloma patients. International Journal of Hematology. 108(6). 580–587. 10 indexed citations
2.
Kawashima, M., Shingo Yano, Takeshi Saito, et al.. (2018). Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era. 7(1). 9–16. 1 indexed citations
3.
4.
Suzuki, Rikio, Shohei Kikuchi, Takeshi Harada, et al.. (2015). Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells. PLoS ONE. 10(12). e0143847–e0143847. 19 indexed citations
5.
Mimura, Naoya, Teru Hideshima, Toshiyasu Shimomura, et al.. (2014). Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition. Cancer Research. 74(16). 4458–4469. 66 indexed citations
6.
Fabre, Claire, Naoya Mimura, Kathryn Bobb, et al.. (2012). Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma. Clinical Cancer Research. 18(17). 4669–4681. 66 indexed citations
7.
Mimura, Naoya, Hiroto Ohguchi, Diana Cirstea, et al.. (2012). TAS-117, a Novel Selective Akt Inhibitor Demonstrates Significant Growth Inhibition in Multiple Myeloma Cells in Vitro and in Vivo. Blood. 120(21). 942–942. 5 indexed citations
8.
Yano, Shingo, Jiro Minami, Kaichi Nishiwaki, et al.. (2011). Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients. International Journal of Hematology. 93(3). 344–350. 6 indexed citations
9.
Minami, Jiro, Nobuaki Dobashi, Osamu Asai, et al.. (2010). Two Cases of Mediastinal Gray Zone Lymphoma. Journal of Clinical and Experimental Hematopathology. 50(2). 143–149. 8 indexed citations
10.
Usui, Noriko, Nobuaki Dobashi, Shingo Yano, et al.. (2010). [High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].. PubMed. 37(7). 1277–82. 1 indexed citations
11.
Nakasone, Hideki, Yoshinobu Kanda, Kenji Matsumoto, et al.. (2009). Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma. American Journal of Hematology. 84(12). 809–814. 15 indexed citations
12.
Yamaguchi, Yuko, Noriko Usui, Nobuaki Dobashi, et al.. (2009). Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.. PubMed. 36(7). 1105–9. 1 indexed citations
13.
Saito, Takeshi, Noriko Usui, Osamu Asai, et al.. (2007). Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF). Journal of Infection and Chemotherapy. 13(6). 426–428. 11 indexed citations
14.
Saito, Takeshi, Noriko Usui, Osamu Asai, et al.. (2007). Pseudo—Gaucher Cell Proliferation Associated with Myelodysplastic Syndrome. International Journal of Hematology. 85(4). 350–353. 7 indexed citations
15.
16.
Minami, Jiro, Koji Takada, Katsuhiko Aoki, et al.. (2006). Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells. The International Journal of Biochemistry & Cell Biology. 39(1). 171–180. 9 indexed citations
17.
Saito, Takeshi, Osamu Asai, Nobuaki Dobashi, et al.. (2006). Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia. Journal of Infection and Chemotherapy. 12(3). 148–151. 9 indexed citations
18.
Yano, Shingo, Noriko Usui, Osamu Asai, et al.. (2005). Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli. Internal Medicine. 44(10). 1100–1102. 2 indexed citations
19.
Ohkawa, Kiyoshi, et al.. (2004). Establishment and some characteristics of epoxomicin (a proteasome inhibitor) resistant variants of the human squamous cell carcinoma cell line, A431. International Journal of Oncology. 24(2). 425–33. 8 indexed citations
20.
Okawa, Yutaka, Koji Takada, Jiro Minami, et al.. (2003). Purification of N-terminally truncated histone H2A-monoubiquitin conjugates from leukemic cell nuclei: probable proteolytic products of ubiquitinated H2A. The International Journal of Biochemistry & Cell Biology. 35(11). 1588–1600. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcos J. Ruiz Breakdown of academic impact, for papers by Alessandra Pirola Breakdown of academic impact, for papers by Jennifer Richmond Breakdown of academic impact, for papers by Gary Simmons Breakdown of academic impact, for papers by Juliana M. Benito Breakdown of academic impact, for papers by Stephanie Nguyen Breakdown of academic impact, for papers by Ling Sun Breakdown of academic impact, for papers by Tracey Perry Breakdown of academic impact, for papers by Amanda L. Robichaud Breakdown of academic impact, for papers by Vladimir Vorobyev
Rankless by CCL
2026